Michael Rapp, 10% Owner at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 10,000 shares at $15.85 ($159K) on 2016-12-29, disclosed to the SEC on 2016-12-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| IMNM | BUY | 2021-05-26 | $1.9M | — | Filing → |
| IMNM | BUY | 2020-10-08 | $1000K | — | Filing → |
| ZYNE | BUY | 2018-05-31 | $123K | — | Filing → |